<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44-microorganisms-08-01620">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bollani</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Baraldi</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Chirico</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Dotta</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lanari</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Del Vecchio</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Manzoni</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Boldrini</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Paolillo</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Di Fabio</surname>
    <given-names>S.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Revised recommendations concerning palivizumab prophylaxis for respiratory syncytial virus (RSV)</article-title>
  <source>Ital. J. Pediatr.</source>
  <year>2015</year>
  <volume>41</volume>
  <fpage>97</fpage>
  <pub-id pub-id-type="doi">10.1186/s13052-015-0203-x</pub-id>
  <pub-id pub-id-type="pmid">26670908</pub-id>
 </element-citation>
</ref>
